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Available online 27 February 2013Phage display antibody libraries have a proven track record for the discovery of therapeutic
human antibodies, increasing the demand for large and diverse phage antibody libraries for
the discovery of new therapeutics. We have constructed naïve antibody phage display libraries
in both Fab and scFv formats, with each library having more than 250 billion clones that
encompass the human antibody repertoire. These libraries show high fidelity in open reading
frame and expression percentages, and their V-gene family distribution, VH-CDR3 length and
amino acid usage mirror the natural diversity of human antibodies. Both the Fab and scFv
libraries show robust sequence diversity in target-specific binders and differential V-gene
usage for each target tested, supporting the use of libraries that utilize multiple display formats
and V-gene utilization to maximize antibody-binding diversity. For each of the targets, clones
with picomolar affinities were identified from at least one of the libraries and for the two
targets assessed for activity, functional antibodies were identified from both libraries.
© 2013 Elsevier B.V. Open access under CC BY-NC-ND license.Keywords:
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Human antibody repertoire1. Introduction
Monoclonal antibodies are a significant and growing class of
therapeutics for a wide range of indications including cancer,
metabolic, and inflammatory diseases. Phage display antibody
libraries are an important tool for the discovery of human
monoclonal antibodies, providing two marketed products, one
under review by the FDA, and many more at various stages of
clinical trials (Nelson et al., 2010). Specificity and affinity are
key components for the successful transition of an antibodyiable; Fab, fragment
r cell; V, variable; VH,
ble kappa light chain;
ct; ORF, open reading
ramework region; TIE,
-like domains; β-gal,
nsR, insulin receptor;
xidase; PBS, phosphate
immer).
 BY-NC-ND license.from the lab to the clinic. Library size and diversity are
extremely important in this endeavor as the larger and more
diverse a library, the greater the chance of finding high affinity
antibodies with diverse paratopes that bind diverse epitopes
(Perelson andOster, 1979; Perelson, 1989; Griffiths et al., 1994;
Vaughan et al., 1996).
The first fully human phage displayed antibody fragment
library had 107 members and antibody fragments to four
proteins were isolated with affinities as low as 86 nM (Marks
et al., 1991). Other groups went on to construct larger human
libraries: two Fab (6.5 × 1010 and 3.7 × 1010) (Griffiths et al.,
1994; de Haard et al., 1999) and one scFv (1.4 × 1010)
(Vaughan et al., 1996). From each library, antibody fragments
with single-digit nanomolar affinities were isolated, and from
the scFv library, two fragments were isolated with affinities
less than 1 nM. However, Fabs with only moderate affinities
(>800 nM) were recovered when selecting from a small
portion of the Griffiths library (107 clones), supporting the
claim that the larger the library, the greater the probability of
isolating high affinity antibodies (Griffiths et al., 1994). To
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XscFv2, which display Fab and scFv fragments, respectively,
each with more than 2.5 × 1011 members maximizing the
potential for isolating high affinity antibodies against any
target of interest.
Antibody diversity is influenced by the number of donors,
donor tissues used, the types of variable regions from which
antibody sequences are amplified and the choice in the
utilization of V-gene frameworks. For each of XFab1 and
XscFv2, variable regions were amplified from thirty racially-
diverse healthy donors using a variety of tissues including bone
marrow, PBMCs, spleen and lymph node. The amplification
strategy encompasses variable domains derived from IgM, IgG,
IgA, IgE and IgD. While other commercial phage display
antibody libraries have restricted antibody frameworks to
enhance stability or expression of the displayed fragments
(Söderlind et al., 2000; Hoet et al., 2005; Rothe et al., 2008), in
the XFab1 and XscFv2 libraries, all prominent V-gene families
encompassing the human repertoire were utilized to allow
increased structural diversity. The performance of a Fab versus
a scFv fragment type depends on factors including stability of
the variable domains and the expression of the individual
molecules (Rothlisberger et al., 2005), as well as the possible
differences in the donor pools. Therefore, the performance
characteristics of each library will differ, making it advanta-
geous to have a variety of libraries available for selection.
Although, fully human naïve Fab and scFv libraries have been
made before (Marks et al., 1991; Griffiths et al., 1994; Vaughan
et al., 1996; de Haard et al., 1999; Glanville et al., 2009; Lloyd et
al., 2009), here we present the first direct comparison between
the performances of the two formats. This comparison can be
done because these two libraries were constructed using
similar donor sources, construction methods and vector
backbones, limiting the variability between the libraries.
Both XFab1 and XscFv2 were assessed for multiple
qualification parameters, including percentage of open reading
frame (%ORF), expression levels, V-gene family distribution,
VH-CDR3 length, and germline occurrence. Our libraries have
been used for selections against seven targets and the resulting
clones analyzed to determine unique hit rate, V-gene usage,
and affinity. These parameters have allowed us to validate and
compare the libraries and demonstrate their utility as potential
sources for high affinity, functional therapeutic antibodies.2. Materials and methods
2.1. Source material, cell lines, enzymes
The source RNA and cDNA used to amplify the V-genes
was purchased from AllCells and Cureline. The E. coli strain
TG1 (Lucigen) was used for all molecular cloning, phage
production, and expression assays. Restriction endonucleases
and T4-DNA ligase were purchased from New England
Biolabs. KOD Hot Start DNA Polymerase and associated 10×
buffer, dNTP mix, and MgSO4 (EMD Biosciences), were used
for all PCR reactions. Some PCR reactions also included
betaine (Sigma-Aldrich) and/or DMSO (Sigma-Aldrich). PCR
primers were purchased from Elim Biosciences or IDT.
ArrayScript™ Reverse Transcriptase (Ambion) with Random
primers (NEB) was used to make cDNA libraries from RNAsamples. All media and solutions were purchased from
Teknova.
For the CHO cells expressing TIE2 and InsR used for
screening, mammalian expression vectors encoding TIE2 and
InsR were each transfected into CHO-K1 cells using a PEI
transfection reagent (JetPEI®, Polyplus). Individual G-418-
resistant clones were screened by FACS using commercially
available antibodies to TIE2 or InsR.
2.2. Library construction
2.2.1. XFab1
XFab1 used cDNA generated from 15 PBMC samples and 15
bone marrow samples. The variable regions were amplified
from cDNA using primers designed based on sequences in
V-Base to amplify each family of Vλ1–Vλ10, Vκ1–Vκ6, and VH1–
VH6 individually with forward primers annealing to the V
segment and reverse primers annealing in the Cλ or Cκ for Vλ
and Vκ and in the VHJ region for VH (Table S1). Secondary PCRs
(Table S2) were performed to add restriction enzyme sites 5′
and 3′ to each V-gene for cloning into pXHMV-US2-L-Fab or
pXHMV-US2-K-Fab vectors (Fig. S1). The PCR products for each
variable region were pooled according to the natural distribu-
tion as described on V-Base. The light chain variable regions
were cloned first using restriction digest with SfiI and AvrII
for Vλ and SfiI and BsiWI for Vκ and transformed into
electrocompetent TG1 cells (48 μg DNA in 48200 μL transfor-
mations for Vκ and 65 μg DNA in 65200 μL transformations
for Vλ). Transformationswere spread on 2xYTmediumwith 2%
glucose and 100 μg/mL carbenicillin, which were incubated
overnight at 30 °C. The following morning the bacteria were
scraped from the plates, combined and plasmid DNA purified
with the GenElute™ HP Maxiprep Kit (Sigma-Aldrich). The
resulting DNA was prepared for cloning VH with NcoI-HF and
NheI-HF. The ligated DNA was cleaned with the Wizard® SV
Gel and PCR Clean-up system (Promega) and transformed into
electrocompetent TG1 cells (66 μg DNA in 66200 μL transfor-
mations for Vκ and 100 μg DNA in 100200 μL transformations
for Vλ). Transformationswere spread on 2xYTmediumwith 2%
glucose and 100 μg/mL carbenicillin, which were incubated
overnight at 30 °C. The following morning the bacteria were
scraped from the plates, combined, and stored in 15% glycerol
2xYT at−80 °C.
2.2.2. XscFv2
The scFv library was constructed similarly to the above
described Fab library with the following changes. Primer
sequences are listed in Tables S3 and S4. cDNA from 20 PBMC
samples, 8 bone marrow samples, 1 lymph node sample, and
1 spleen sample were used. The reverse secondary PCR
primers for VH and forward secondary primers for Vκ and Vλ
had complementary extensions for an AST(G4S)3 linker and
the forward secondary PCR primers for VH and reverse
secondary primers for Vκ and Vλ had sequences to add
flanking SfiI restriction sites. A tertiary PCR step was then
done to assemble the full length scFv fragment, which was
next cloned into pXHMV-scFv (Fig. S1) using the SfiI sites.
The ligated DNA was transformed into electrocompetent TG1
cells (147 μg DNA in 120200 μL transformations for Vκ and
44 μg DNA in 40200 μL transformations for Vλ). Transforma-
tions were spread on 2xYT medium with 2% glucose and
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at 30 °C. The following morning the bacteria were scraped
from the plates, combined, and stored in 15% glycerol 2xYT at
−80 °C.2.3. Phage rescue
Both XFab1 and XscFv2 phage libraries were rescued using
a modification of the standard protocol (Marks et al., 1991).
XFab1 was rescued in four batches (two for XFab1λ and two
for XFab1κ) each starting with 5-fold more bacteria than the
sub-library size. XscFv2 was rescued in five batches (two for
XscFv2λ and three for XscFv2κ) with XscFv2λ starting 5-fold
more bacteria than the sub-library size and XscFv2κ starting
with 3.33-fold more bacteria than the sub-library size. For all
rescue batches, cultures were seeded at a starting density of
0.1 OD600 in 2xYT medium with 2% glucose and 100 μg/mL
carbenicillin and grown at 37 °C with shaking at 250 rpm
until the OD600 reached 0.5. Half of the culture was then
infected with 20 MOI M13KO7 and incubated at 37 °C for 1 h
(30 min with no shaking and 30 min with shaking at
100 rpm). The culture was then centrifuged at 3000 RCF for
20 min. The pellets were resuspended in the same volume of
2xYT medium with 100 μg/mL carbenicillin and 50 μg/mL
kanamycin. These cultures were grown 18 h at 25 °C with
shaking at 250 rpm. Next, the cultures were centrifuged at
9000 RCF for 30 min and phage particles were purified from
the supernatant by two PEG-precipitations (Sambrook and
Russell, 2001). After the second precipitation, phage were
resuspended in 1% of the initial volume with 15% glycerol in
PBS and stored at−80 °C.2.4. Selection of phagemid libraries
Selections against biotinylated gastrin 14-mer (Anaspec),
β-galactosidase (Sigma), TIE-1-Fc chimera (R&D Systems),
TIE-2 (R&D Systems), TIE-2/Ang2 (R&D Systems) and TIE-2/
Ang1 (R&D Systems) were performed using solid or solution
phase panning as previously described (Hawkins et al., 1992;
Vaughan et al., 1996). Complexes of TIE-2 with Ang1 and
Ang2 were formed in a 1:1molar ratio prior to incubation with
magnetic beads. Prior to panning, TIE1-Fc and TIE2 were
biotinylated with the EZ-Link Sulfo-NHS-LC-Biotin, No-Weigh
Format (Thermo). InsR panningswere performed as previously
described (Bhaskar et al., 2012).2.5. Sequencing and sequence analysis
RCA sequencing was performed by either ELIM Biosciences
or Sequetech. Sequenceswere analyzed for open reading frame
(ORF), variable region family, and alignment to germline
sequences. ORF and V-gene family were determined using
SeqAgent™ (XOMA (US) LLC) following IMGT conventions. To
determine percentage of germline representation in the naïve
libraries and selected clones, V-Base germline DNA sequences
were used as references. For each V-gene sequence, BLAST was
used to find the closest germlinematch, followed by alignment
of the two sequences using Clustalw2. The differences between
the two sequences were then counted.2.6. ELISA
Periplasmic extracts (PPE) of soluble scFvs and Fabs were
prepared by growing 1 mL cultures of 2xYT medium with
0.1% glucose and 100 μg/mL carbenicillin to an OD600 of 0.5 at
37 °C with shaking in 96-well deep well plates. IPTG was
then added to a final concentration of 1.25 mM and the
cultures were grown 16 to 18 h at 30 °C with shaking. The
cultures were pelleted and the supernatant removed. The
pellets were resuspended in 75 μL PPB (Teknova) with
protease inhibitors (Roche) and incubated for 10 min at
4 °C with shaking. Next, 225 μL of sterile water with protease
inhibitors was added and incubated for 1 h at 4 °C with
shaking. Cell debris was removed via centrifugation and the
supernatant was removed as PPE.
Phage displaying scFv and Fabs were prepared by growing
1 mL cultures of 2xYTmediumwith 2% glucose and 100 μg/mL
carbenicillin to an OD600 of 0.5 at 37 °Cwith shaking, usually in
96-well deep well plates. Next, 20 MOI of M13K07 helper
phage was added to each well and allowed to infect for 1 h
at 37 °C. After infection, the cultures were pelleted and
resuspended in 1 mL 2xYT with 100 μg/mL carbenicillin and
50 μg/mL kanamycin and the cultures were then grown 16 to
18 h at 30 °C with shaking. Cells were removed via centrifu-
gation and the supernatant was removed as phage.
For ELISA of PPEs, 96-well Maxisorp™ or Immulon-4 plates
were coated with capture antibody (mouse anti-human IgG Fd
(Millipore) for Fab or monoclonal anti-V5 (Sigma) for scFv) or
antigen at 4 °C overnight. Plates were washed 3 times between
each step with PBST (PBS + 0.05% Tween-20). Plates were
blockedwith either 5%milk or 10% casein in PBST for 1 h. After
washing, PPEs were added to the plate and incubated for 1 h at
room temperature. Plates were then washed and detection
antibody was added (goat anti-human κ-HRPO (Invitrogen) or
goat anti-human λ-HRPO (Invitrogen) for Fab, anti-His-HRP
(Sigma) for scFv, or anti-V5 for antigen coated plates) and
incubated for 1 h at room temperature. For antigen coated
plates, after washing secondary antibody (goat α-mouse IgG
(H + L), peroxidase conjugated (Thermo)) was added and
incubated for 1 h at room temperature. Plates were then
washed and HRP activity was detected with TMB Microwell
Peroxidase Substrate System (KPL).
For ELISA of phage, 96-well Maxisorp™ or Immulon-4
plates were coated with capture antibody (goat anti-human κ
(Invitrogen) or goat anti-human λ (Invitrogen) for Fab or
monoclonal anti-V5 (Sigma) for scFv) at 4 °C overnight.
Plates were washed 3 times between each step with PBST.
Plates were blocked with either 5% milk or 10% casein in PBST
for 1 h. After washing, phage were added to the plate and
incubated for 1 h at room temperature. Plates were then
washed and anti-M13-HRP antibody (GE Healthcare) was
added and incubated for 1 h at room temperature. Plates
were then washed and HRP activity was detected with TMB
Microwell Peroxidase Substrate System (KPL).
2.7. Functional pAKT assays
CHOK1 cells engineered to express the TIE2 or InsR
receptor were used. These cells were maintained in Growth
Medium containing EX-CELL® 302 Serum-Free Medium for
CHO Cells (Sigma-Aldrich), 2 mM L-glutamine, and 0.4 mg/mL
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were washed and resuspended at 4 × 106 cells/mL in PBS with
0.5% BSA and incubated for 3 h at 37 °C, 5% CO2 incubator. The
test antibody or antigen was added for 10 min. For InsR + Ins,
375 pM insulin was added to the cells before incubation
with antibody. After incubation, the treated cells were
centrifuged and lysed in a buffer containing 20 mM Tris–HCl
(pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton
X-100, 10 mM NaF, Phosphatase Inhibitor Cocktails 1 and 2
(Sigma-Aldrich), and Complete Mini Protease Inhibitor (Roche
Diagnostics Corporation) for 1 h with shaking at 4 °C. The
lysates were clarified by centrifugation at 485 ×g for 3 min.
The MULTI-SPOT Assay System (Meso Scale Discovery) was
used to quantify the amount of phosphorylated AKT or MAPK
presentwithin the lysates. Data were analyzed using GraphPad
Prism® (GraphPad Software Inc.) software.2.8. KD determinations
2.8.1. IgG capture chips
Monoclonal mouse anti-human IgG (Fc) antibody (GE
Healthcare) was immobilized for capture on a Biacore A100
C1 Series S Biacore biosensor (GE Healthcare) by standard
amine coupling. 100 to 200 RU of anti human IgG was
immobilized on spots 1, 2, 4, and 5. Spot 3 was not used.
Amine coupling was performed by activating the chip with
EDC/NHS (GE Healthcare) for 10 min and injecting anti human
IgG solutions at 2 μg/mL in pH5.0 acetate (GE Healthcare) for
7 min. Deactivation was performed with 1 M ethanolamine.2.8.2. TIE2 IgG kinetics
TIE2 IgG were diluted to 1 μg/mL in assay running buffer
and injected over anti human IgG for 4 min at 10 μL/min.
TIE2 was injected over captured anti-TIE2 IgGs at five
concentrations starting at 30 nM, four fold serial dilution
created additional concentrations of 7.5 nM, 1.875 nM,
0.468 nM, and 0.117 nM. Injections were 4 min each at
30 μL/min in duplicate. Dissociation times were 5 min.
Running buffer was HBS-EP (GE Healthcare) 10 mM HEPES,
150 mM NaCl, 3 mM EDTA, 0.05% Surfactant P20 at
pH 7.4 with 1 mg/mL BSA (Sigma). The capture surface was
regenerated following each analyte injection with 3 M MgCl2
(GE Healthcare).2.8.3. Fab and scFv fragment capture chips
Antibody fragment capture surfaces were prepared on
Biacore A100 CM5 Series S biosensors (GE Healthcare).
Antibody was immobilized for capture on spots 1, 2, 4, and
5 by standard amine coupling. Spot 3 was not used. Fab
capture utilized goat anti-human IgG (Fab specific) antibody
(Jackson ImmunoResearch); scFv capture utilized monoclo-
nal anti-6X histidine antibody (R&D Systems). Amine cou-
pling was performed by activating the chip with EDC/NHS
(GE Healthcare) for 10 min and injecting antibody solutions
at 5 μg/mL in pH4.5 acetate (GEHealthcare) for another 10 min.
Approximately 3000 to 4000 RU of goat anti-human IgG (Fab
specific) antibody or 6000 to 8000 RU of anti-6X histidine
antibody was immobilized. Deactivation was performed with
1 M ethanolamine.2.8.4. Fab and scFv kinetics
Fab or scFv periplasmic extracts were diluted 1:1 in assay
running buffer and filtered through 0.22 μm multiscreen GV
filter plates (Millipore). Filtered periplasmic extracts were
injected over anti-Fab IgG (for Fab PPE) or anti-6xHistidine
IgG (for scFv) capture surfaces. TIE1 or β-gal was injected
over captured Fab or scFv at two concentrations (100 nM and
50 nM for TIE1 and 100 nM and 25 nM for β-gal). Injections
were 5 to 6 min each at 30 μL/min. Dissociation time was
15 min for TIE1 and 10 min for β-gal. Running buffer was
HBS-EP (GE Healthcare) at pH 7.4 with 1 mg/mL BSA
(Sigma). These assays conditions favor monomeric scFv
(Desplancq et al., 1994; Arndt et al., 1998; Dolezal et al.,
2000). The capture surface was regenerated following each
analyte injection with 100 mM HCl. Data was double
referenced by subtracting the reference spot within the
flow cell which was an activated and deactivated blank
surface as well as subtracting out blank (0 nM) injections.
After referencing, the data were fitted to a 1:1 Langmuir
interaction model using Biacore A100 evaluation software.
2.8.5. InsR afﬁnity
Affinities of anti-InsR antibodies were determined as
previously described (Rathanaswami et al., 2008). Briefly,
the antibodies were incubated at a fixed 50 pM concentration
with a titration series of human InsR expressing CHO-K1 cells
at 5 °C for 18 h in PBS with 0.5% BSA and 0.1% sodium azide.
Cells were removed by centrifugation and the amount of free
antibody in the supernatant was measured by a sandwich
immunoassay. Unbound antibody concentration data were
curve-fit using KinExA™ software to yield the estimated
affinity (KD) values.
2.9. Screening by high-throughput ﬂow cytometry for TIE2 or
InsR binding
Suspension adapted CHO-K1 cells transfected with either
human TIE1 or TIE2, and the parent cell-line were used in this
assay. CHO-K1 cells were labeled with 600 nM CSFE
(Invitrogen) and CHO-TIE1 cells were labeled with 100 nM
CSFE (Invitrogen). Unlabelled CHO-TIE2 cells were mixed in
equal numbers with the labeled TIE1 and CHO-K1 parent
lines and the cell concentration adjusted to 2 × 106 cells/mL
in FACS buffer (PBS (Life Technologies) with 0.5% BSA
(Sigma-Aldrich) and 0.1% sodium azide (Sigma-Aldrich)).
Twenty-five microliters of the cell mixture was added to
25 μL of PPE and the suspension incubated at 4 °C for 60 min.
The cells were then washed once with FACS buffer and the
pellet resuspended in 25 μL of 1:1000 dilution of mouse
anti-c-myc antibody (Roche) and incubated at 4 °C for
30 min. The cells were then washed once with FACS buffer
and the pellet resuspended in 25 μL of 1:200 dilution of
Alexa-647 conjugated goat anti-mouse antibody (Jackson
ImmunoResearch) and incubated at 4 °C for 15 min. The cells
were then washed once with FACS buffer and the pellet
resuspended in 60 μL FACS buffer and analyzed on a FACScan
(BD) modified by Cytek to have an AMS and Hudson plate
crane. The resulting data were analyzed by FlowJo (Treestar)
and Excel. Screening for PPEs that bind InsR was performed
as previously described (Bhaskar et al., 2012).
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3.1. Fab and scFv library construction
The XFab1 and XscFv2 libraries were constructed using
cDNA made from RNA isolated from bone marrow, PBMCs,
spleens, or lymph nodes of thirty healthy donors for each
library, with each library using different donors. The samples
included RNA from at least 1 × 107 B-cells per library,
therefore, accounting for random pairing of heavy and light
V-genes, our theoretical maximum library size for each library
was 1 × 1014. This cDNAwas used as a template with V-region
specific primers (Tables S1–S4) to amplify the VH, Vλ and Vκ
regions of antibodies derived from the natural antibody
repertoire, including IgM, IgG, IgD, IgA and IgE. For the XscFv2
library, all variable gene families annotated within V-Base
(vbase.mrc-cpe.cam.ac.uk) were included in proportion to the
theoretical human representation as described (Fig. 1). For
XFab1, Vλ9 and VH7 were not included due to restriction
enzyme incompatibility and lack of amplification specificity,
respectively.
For both libraries, Vλ and Vκ were independently cloned
into phagemid vectors (Fig. S1) creating λ and κ sub-libraries,
with XFab1κ (1.1 × 1011) plus XFab1λ (1.4 × 1011) having
2.6 × 1011 total members and XscFv2κ (2.8 × 1011) plus
XscFv2λ (8.2 × 1010) having 3.6 × 1011 total members. Both
vectors contain an amber stop codon between the antibody
fragment and the phage gene 3, enabling soluble expression
as well as display. Each antibody fragment (scFv or Fab VH) is
linked to a triple tag (6xHis, c-myc, and V5) to enable
detection, capture and purification. The triple tag provides
much needed flexibility, since many commercially available
antigens utilize one or more of the individual tags above,
disallowing their use in an assay with the antigen. Moreover,
the V5 tag and 6xHis can be utilized simultaneously to
capture and detect the soluble antibody fragment in an ELISA,
allowing the determination of soluble antibody expression,
as described below.
The percentage of clones with full length open reading
frame (ORF) ranges from 66% to 85%. Between 58% and 85% of
clones express soluble protein as assessed by ELISA (Table 1).0
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Fig. 1. Frequency of variable region families in the naïve XFab1 (gray) and XscFv
Variable heavy (VH) family frequencies were calculated as a compilation of the VκBoth libraries also have similar distributions of VH-CDR3
lengths (Fig. 2) each with an average amino acid length of
15.3, which is similar to the distribution of VH-CDR3 lengths
of functional antibodies in the IMGT database (Giudicelli et
al., 2006).
The V-genes from each library were also assessed for amino
acid changes from germline sequences for FR1 through FR3
(Fig. 3A). Both libraries have similar average amino acid
changes from germline sequences of less than two per segment
in all but VH-FR3. VH-FR3 has greatest number of amino acid
differences, averaging three amino acid differences per se-
quence. These differences are distributed throughout VH-FR3,
with no amino acid position contributing more to the diversity
than others. Overall, the percentage of germline representation
in the V-genes (FR1–FR3) ranges from 5.6% to 20.7% (Fig. 3B).
The difference between the Vλ germline representation in
XFab1 and XscFv2 can be accounted for by the difference in
primers used to amplify these V-regions. For XscFv2, thirty-
three primers were used to increase the specificity of the
priming for each Vλ-gene family and subfamily over the
eighteen primers used for Vλ priming for XFab1 (Tables S1
and S3). Since the primers were designed based on germline
sequences, the result of having primers that aremore specific is
a decrease in natural diversity in FR1. To visualize more clearly
the diversity of the libraries from germline sequences, Fig. 3C
depicts the distribution of differences from germline sequences
for each library. The majority of light chains have 5 or fewer
differences from germline and the majority of heavy chains
have 8 or fewer differences. For VH, when there are more than
twelve differences from germline, most of these differences are
in FR3, which is reflected in the data presented in Fig. 3A.
Whilst having antibody sequences as close to germline as
possible may be desirable to avoid potential immunogenicity,
mutations may be required to enhance affinity and/or
specificity of antibodies for specific targets.
The pairing of heavy and light chain V-genes from each
family occurs in proportion to their abundance in the library
(data not shown), indicating random pairing as expected
with the library construction method that was employed.
Previous data suggests random pairing also occurs in the
human repertoire (de Wildt et al., 1999).Expected XFab1 XscFv2
2 (white) libraries compared to the expected frequency per VBase (black).
(VK) and Vλ (VL) sub-libraries.
Table 1
Phage library characterization. Percentage open reading frame (%ORF) is
calculated based on the number of sequences with complete open reading
frame between start of signal sequences through the end of both the VL and
VH for XFab1 and from the start of the signal sequence through the end of
the VL for XscFv2. Percentage expression is based on the number of clones
that had an OD450 >3-fold about background in an ELISA for periplasmic
expression of Fab or scFv. The library size is expressed as colony forming
units (cfus) from the transformation of the libraries.
XFab1 XscFv2
Vκ Vλ Vκ Vλ
% ORF 76 85 74 66
% Expression 70 85 71 58
Size 1.1 × 1011 1.4 × 1011 2.8 × 1011 8.2 × 1010
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fragments
Each library was assessed by selection against seven
targets: gastrin (a 14 amino acid peptide), β-galactosidase
(a bacterial protein, β-gal), human proteins insulin receptor
in complex with insulin (InsR + Ins), TIE1, TIE2, TIE2 in
complex with angiopoeitin 1 (ANG1), and TIE2 in complex
with angiopoeitin 2 (ANG2). Three rounds of panning were
performed for each target using previously described pan-
ning methods (Hoet et al., 2005; Bhaskar et al., 2012). For
each target, five to ten 96-well plates of clones were screened
either by ELISA (gastrin, β-gal, TIE1, TIE2, and TIE2 com-
plexes) or flow cytometry (InsR + Ins (Bhaskar et al., 2012),
TIE2, and TIE2 complexes) for binding to the target. The
clones that bound to their target were sequenced to identify
unique clones. The unique clones were then analyzed for VH
and VL family representation (Fig. 4), for CDR3 length of the
VH and VL, and to assess the germline representation in FR1–
FR3 of the selected clones (Table 2).
Once unique clones were identified for each target,
further characterization of those clones was performed. For
both libraries, the unique clones that bound to β-gal and TIE1
were prepared as soluble antibody fragments in periplasmic
extracts (PPE) and the KD (equilibrium dissociation constant)0
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Fig. 2. Length distribution of VH-CDR3 sequences from 6580 rearranged and
productive human Ig-heavy cDNA or RNA sequences from the IMGT
database (shaded), 351 naïve XFab1 (solid line), and 210 naïve XscFv2
(dashed line) sequences.was determined using Biacore. For both targets, multiple
antibody fragments with high affinities (single-digit nM to
triple-digit pM) were identified. Table 2 lists the best KD
identified for each target per library (Fig. S3).
When screening the panning campaigns of TIE2 in
complex with either of its ligands (ANG1 or ANG2), antibody
fragments in PPE were screened by flow cytometry for
binding to TIE2 or TIE2–ligand complex, and screened by
ELISA for binding to ANG1 or ANG2. Binders in three
categories emerged: single-protein binders (TIE2, ANG1 or
ANG2), TIE2/ANG1-complex binders, or TIE2/ANG2-complex
binders (Table 3). A subset of 10 Fab clones and 8 scFv clones
that bound TIE2 was reformatted as IgG and the KD for each
clone was determined with Biacore (Table 2 and Fig. S3). For
clones from XscFv2, 6 out of 8 clones have KDs > 8 nM. For
clones from XFab1, 9 out of 10 have KDs > 11 nMwith two of
these clones having KDs in the pM range (Fab09 = 800 pM
and Fab10 = 500 pM).
3.3. Analysis of selected clones
The sequences of the 591 unique selected clones for both
libraries were compared to each other and aligned to the
closest germline sequence. Of the 591 unique sequences that
bound to the seven targets, there was no overlap in VH-CDR3
sequences between those selected from XFab1 versus XscFv2,
and the percentage of germline representation in the selected
clones was comparable to that in the naïve library (Fig. 3B).
Next, the V-gene family usage of the selected clones was
compared to that of the naïve library. We found that the
family V-gene distribution of the selected clones (Fig. 4) was
significantly different from the naïve library using a χ2 test
(p b 0.002 in all cases). Clones selected from XFab1 have
more representatives from Vλ4–Vλ10 than those selected
from XscFv2. In fact Vλ5, which makes up less than 5% of
naïve XFab1, was over-represented in the selected Fab clones,
with more than 20% of the clones having a light chain from
this family. XscFv2 did not show this same preference for
Vλ5. Also, families VH2, VH7, Vλ9, Vλ4, and Vκ5 were notably
underrepresented in the selected clones of both libraries
(note: VH7 and Vλ9 were not included in XFab1). Target
specific differences in V-gene usage were also evident. For
example, despite the low representation of VH5 in the bulk
libraries (3–5%), 22% to 30% of the clones that bound to the
InsR utilized VH5 domain. There were also format specific,
target dependent V-gene usage differences. For example,
clones from the β-gal panning with XscFv2 had more VH1
representation than VH3, but with XFab1, VH3 was more
represented than VH1. The opposite was seen in the InsR
panning. We also noted that for all panning with XscFv2,
more clones with kappa light chains were selected than those
with lambda light chains, which may have been a reflection
of the difference in size of the two sub-libraries (Table 1). In
general, the selected clones from each library showed similar
preferences for VH–VL family pairs. For selected clones from
both libraries, VH1 was often paired with Vλ3 and Vκ1, and
VH3 was often paired with Vλ3, Vκ1, Vκ2, and Vκ3. However
there were some differences in family pair preference
between the libraries for selected clones. For XscFv2, VH1
was also often paired with Vκ2, and VH3 with Vλ1, and Vκ4.
For XFab1, VH3 was also often paired with Vλ5.
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To further validate these libraries, functional activity was
assessed for two of the seven targets tested. Since ANG1/TIE2
interaction is known to mediate phosphorylation of Akt
through PI3 kinase (DeBusk et al., 2004), IgG reformatted
-TIE2 antibodies from XFab1 and XscFv2 were screened for
their ability to promote Akt phosphorylation via activation of
TIE2. Using the MesoScale Discovery Multi-spot Assay System,
the phosphorylation level of serine 473 of Akt (pAKT) was
measured after CHOK1 cells expressing human TIE2 on their
surface were incubated with ANG1, -KLH (as a control) or the
antibody of interest at 10 or 50 μg/mL. Eight of the eighteen
antibodies tested induced AKT phosphorylation to at least 50%
of the level induced by an endogenous agonist ANG1, with
Fab05 (KD = 7.8 nM) equaling the ANG1 pAKT level (Fig. 5).
The interaction between insulin and InsR also mediates
phosphorylation of Akt at serine 473. Several high affinity
antibodies for InsR selected from each library were also
shown to be functionally active as IgG2s. Examples of three
InsR agonist antibodies are shown in Fig. 6A. scFv20 activates
InsR 27% relative to activation by insulin and has an affinity of
230 pM. Fab20 and Fab21, as IgG2s, activate InsR by greater
than 50% with affinities of 24 pM and 27 pM, respectively.
In addition to agonists, positive and negative allosteric
modulating antibodies were identified (Bhaskar et al., 2012)(Fig. 6B). The positive allosteric modulator, scFv21 as an
IgG2, did not significantly activate InsR without insulin,
however, in the presence of insulin there was a significant
increase in AKT phosphorylation with the addition of
antibody. As an IgG2, the affinity of scFv21 for InsR in
the absence of insulin could not be determined because
it bound so poorly, however, in the presence of insulin,
the KD was 1.6 nM (data not shown). For the negative
allosteric modulator, scFv22, a decrease in AKT phosphor-
ylation was seen with the addition of antibody (IgG2) in
the presence of insulin. The binding affinity of scFv22 as an
IgG2 (KD = 50 pM) to InsR was the same in the presence
or absence of insulin.
3.5. Amino acid usage in naïve and selected VH-CDR3s
The VH-CDR3 confers the majority of the contacts between
the antibody and antigen, and is therefore amajor contributor to
the specificity and affinity of the antibody (Amit et al., 1986;
Kabat and Wu, 1991). To analyze the amino acid usage of the
two libraries, the VH-CDR3 sequences of naïve and selected
clones were compared to VH-CDR3 sequences from 6580
productive human antibody sequences from the IMGT database
(Giudicelli et al., 2006).While the amino acid distributions of the
naïve and selected clones were, statistically, not the same as the
IMGT distribution (χ2 test, p b 0.003), the same general trends
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VH-CDR3s (Zemlin et al., 2003) (Fig. 7). Notably, the selected
clones appeared to have a greater percentage of tyrosine and
glycine, but fewer cysteines than the naïve libraries or the
antibodies in IMGT.Table 2
Panning results summary. XFab1 and XscFv2 panning results against seven target an
screened clones with >3-fold ELISA signal above background, the percentage of scre
acid sequences. The unique clones were also characterized by CDR3 length and alig
constants (KD) were measured (see materials and methods). KD for the clone with
XFab1
Target Screened % Positive % Unique
B-gal 744 25 7
Gastrin 465 33 5
Tie1 744 10 3
Tie2 837 35 8
Tie2/Ang1 930 48 10
Tie2/Ang2 837 28 11
InsR 744 16 4
Average 28 7
XscFv2
B-gal 744 54 5
Gastrin 558 67 17
Tie1 744 36 10
Tie2 930 62 11
Tie2/Ang1 930 85 5
Tie2/Ang2 930 88 14
InsR 744 16 7
Average 58 10
a Lowest KD measured.4. Discussion
The XFab1 and XscFv2 librarieswere constructed to capture
the diversity of the human antibody repertoire. Each library
was generated from secondary lymphoid tissue from thirtytigens are characterized by the number of clones screened, the percentage of
ened clones with >3-fold ELISA signal above background and unique amino
ned to germline antibody sequences. For some the the antigens, dissociation
the highest affinity for its target listed here.
Average Length % Germline
VH CDR3 VL CDR3 VH VL KD (nM)a
11.6 8.2 6 13 1.0
12.1 8.4 4 13 ND
15 8.4 9 5 2.1
14.8 10.3 20 3 0.5
13.5 10.3 12 1 ND
15.8 10.5 23 4 ND
14.9 9.2 22 7 0.02
14.0 9.3 14 7
16.1 8.4 13 36 0.01
15 7.7 16 23 ND
13.4 8 15 8 0.1
13.9 9.8 18 15 1.5
13.8 10.2 14 18 ND
15 9.8 19 16 ND
13.4 8.7 22 14 0.23
14.4 8.9 17 19
Table 3
Panning against protein complexes. The distributions of antigen binding for
antibody fragments that were selected from XFab1 or XscFv2 with panning
done against TIE2/ANG1 or TIE2/ANG2 complexes are shown.
Library Target # Screened TIE2 ANG1 ANG2 Complex
XFab1 TIE2/ANG1 837 6 56 NA 53
XFab1 TIE2/ANG2 837 23 NA 55 26
XscFv2 TIE2/ANG1 930 5 21 NA 26
XscFv2 TIE2/ANG2 930 41 NA 71 44
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250 billion antibody fragments, making both libraries larger
than any of the previously published libraries (Sblattero and
Bradbury, 2000; Lloyd et al., 2009; Urlinger, 2011). These
libraries encompass the full spectrum of V-gene families from
IgM, IgG, IgE, IgA and IgD classes of immunoglobulins. The
random pairing of VH and VL domains within and between
donors increases the diversity by producing novel antibodies
with heavy and light chain combinations that do not exist
within the donor pool. The diversity of the VH-CDR3 also
mimics the human repertoire diversity in length and amino
acid representation and distribution (Figs. 2, 7, and S2).
Upon selection, XFab1 and XscFv2 yield a high hit rate of
unique antibody fragments which retain the diversity of the
naïve libraries in VH-CDR3 composition and germline repre-
sentation. In the initial selections, XscFv2 yielded a higher
percentage of clones that bound the target and a slightly higher
percentage of unique clones than XFab1 (Table 2). However,
more clones from XFab1 retain binding to the target upon
reformatting to IgG than from XscFv2, so the yield of unique
and functional clones from each library is typically balanced.
Also, the retention of germline representation after selection
allows the choice of a germline antibody for development,
which may have less potential for immunogenicity.
Theoretically, the larger and more diverse an antibody
library, the greater the probability of discovering a high
affinity antibody for any target (Perelson and Oster, 1979;
Perelson, 1989). According to Perelson, an antibody reper-
toire can be considered complete, having the ability to
recognize any antigen, with only 105 members. However, just
recognizing an antigen does not guarantee that the antibody
will have the desired affinity or effect and increasing the
repertoire size increases the probability of finding a high
affinity antibody (Perelson, 1989). Griffiths and coworkers
have demonstrated that a larger library yields higher affinity
antibody fragments than a smaller subset of the same library
(Griffiths et al., 1994). Here we demonstrated that with largeFig. 5. Phosphorylation of AKT through activation of TIE2 by ANG1 or anti-TIE2 IgGs
are expressed as percentages of pAKT induced by 10 μg/mL of ANG1. For each pairantibody fragment libraries, XFab1 (2.5 × 1011) and XscFv2
(3.6 × 1011), antibodies and antibody fragments with pico-
molar affinities for multiple target antigens can be readily
discovered (Table 2). For two targets we also performed
functional assays and demonstrated that antibodies selected
from these libraries are functional and are able to activate their
target antigen. In addition to the antigens presented in this
paper, these libraries were used for other therapeutic antibody
programs. For those programs, antibodies with high affinity
(b1 nM) and the desired function were discovered by
screening fewer than 4000 clones and some with as few as
1000 clones screened. Also, for the majority of these programs
affinity maturation will not be required.
The selected clones continued to represent the diverse
populations from which they were selected. We continued to
see a variety of V-gene families, although the distribution is
different from that in the naïve libraries, and also varies
according to target antigen (compare Figs. 1 and 4). Including
all the prominent V-gene families in these libraries maximized
the paratope diversity of the antibody fragments. The utiliza-
tion of multiple V-gene families would not have evolved in the
antibody generation process if they were not important for the
function of the immune system and recognition of a multitude
of antigens. One surprising example was the discovery by Sui
and coworkers of broadly neutralizing anti-influenza activity of
antibodies derived from the VH1–69 germline family (Sui et al.,
2009). The VH1–69 family adopts a rare type-2 canonical
structure CDRH2 loop, and consistently encodes two hydro-
phobic residues, including a unique germline Phe at the tip of
the loop. Single framework phage display libraries (not built
upon the VH1–69 family) would have missed the unique
structural reactivity provided by the VH1–69 framework,
thereby supporting use of the human repertoire of antibody
frameworks in our libraries.
Sequence diversity in antibody frameworks is also
important, as it directly affects the CDR loop conformation
and orientation of VH–VL packing, thereby influencing the
antibody paratope. VH2, VH4, and VH6 families are predicted
to adopt type 2 and type 3 canonical structures in CDRH1 and
type 1 and type 5 canonical structures in CDRH2. In contrast,
the major V-gene families VH1 and VH3 are predicted to
adopt type 1 CDRH1 and primarily type 2, 3, and 4 CDRH2
loops (Vargas-Madrazo et al., 1997). Additionally, the VH–VL
packing angle was better predicted when only framework
residues were considered, suggesting that the influence of
CDR residues on VH–VL orientation is small (Abhinandan and
Martin, 2010). Antibody libraries that do not include thederived from XFab1 or XscFv2 with anti-KLH used as a negative control. Data
, the left bar is 10 μg/mL antibody and the right bar is 50 μg/mL antibody.
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limited in paratope diversity.
For the selections performed against InsR + Ins, antibody
fragments with VH5s were over-represented (Fig. 4). Interest-
ingly, 64% of the negative allosteric InsR modulators (Fig. 6B,
scFv226) utilize the VH5 framework, whereas antibodies with
other functions have no preference or favor the major VH
families, VH1 and VH3 (data not shown). Perhaps, this frame-
work structure allows access to an InsR epitope not accessible by
other frameworks.
Antibodies selected from XFab1 had greater representa-
tion from some of the minor Vλ families compared to
antibodies selected from XscFv2. This was especially evident
for Vλ5, which was vastly over-represented in the selected
Fab clones (20%) versus its representation in the naïve XFab10%
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Fig. 7. Distribution of amino acid representation in VH-CDR3 for amino acids 1
abbreviations are used on the x-axis and are in order of their hydrophobicity usinglibrary (5%). It is known that the CH–CL heterodimer, which is
not present in a scFv, contributes additional stability to the
Fab fragment (Rothlisberger et al., 2005). Although, to our
knowledge, an investigation of the stability of each VL family
has not been published, we hypothesize that the stabilizing
effect of CH–CL allowed for selection of a wider variety of VL
families from the XFab1 library than the XscFv2 library. The
preference for some V-gene families over others and the
difference between the two formats may warrant further
investigation of the stability and expression of each V-gene
family in prokaryotes.
The diversity of the VH-CDR3 amino acid sequences of the
selected clones is particularly important as the VH-CDR3 is
the major contributor of contacts between the antibody and
its antigen (Amit et al., 1986; Kabat and Wu, 1991). TheS T G A M C F L V I
aive XFab1 Selected XscFv2 Selected
07 through 114 according to IMGT numbering. Single letter amino acid
the Kyte–Doolittle Index (Eisenberg, 1984).
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selected fromour librarieswas similar to the naïve libraries and
functional clones in the IMGT (Giudicelli et al., 2006) database
(Figs. 7 and S2) and fromprevious analyses (Ivanov et al., 2002;
Zemlin et al., 2003). The preferences for Tyr (for affinity
(Fellouse et al., 2004; Birtalan et al., 2008)) and Gly (for
flexibility (Mian et al., 1991; Padlan, 1994; Zemlin et al., 2003))
were especially evident in the clones selected fromour libraries
and were not unexpected since this amino acid preference is
conserved across vertebrate species (Golub et al., 1997). On the
other hand, Cys was under-represented in the selected clones.
Where Cys did occur, it was in longer than average VH-CDR3s
and it occurred in pairs with three- to four-amino acid spacing.
For these clones, disulfide bonded loops are likely to occur
(Ramsland et al., 2001), probably adding stability to these
loops. The Asp–Arg salt bridge that existed in approximately
60% of the selected clones may also contribute stability to the
VH-CDR3 (Zemlin et al., 2003).
We also demonstrated that in a single panning campaign it
was possible to discover antibodies against multiple targets.
After panning of TIE2 in combination with its ligand (either
ANG1 or ANG2), antibody fragments that bound to TIE2 alone,
ANG1 or ANG2 alone, or TIE2 in complex with ANG1 or ANG2
were recovered. The antibody fragments that bound only
to the complexes of TIE2 are particularly interesting, and
perhaps, were binding to new epitopes created in the complex
formation.
In conclusion, we created two large and diverse antibody
fragment phage display libraries to enable the discovery of
therapeutic antibodies. From these libraries, functional clones
with high affinity were selected for multiple antigens. The
ability to select high affinity antibodies from these libraries
minimizes the need for affinity maturation and allows re-
searchers to focus on screening for clones with the desired
binding properties and functionality.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.jim.2013.02.010.
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